Freenome: Funding, Investors & Team (Oct 2026)
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention. Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.
Freenome has raised $985M across 5 funding rounds on record, the most recent an undisclosed round of $75.0M announced in Nov 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Freenome Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Freenome Funding Rounds
Freenome raised $270M in an undisclosed round announced in Aug 2020.
1.3 years later, a Series D of $300M was announced in Dec 2021.
1 month later, a Corporate Round of $290M was announced in Jan 2022.
3.6 years later, an undisclosed round of $50.0M was announced in Aug 2025.
3 months later, an undisclosed round of $75.0M was announced in Nov 2025.
Freenome Founders and Leadership Team
Contact details for the Freenome team: 3 of 4 have an email address on file.
Start 14-day free trial →Freenome Funding Compared to Other Biotechnology Startups
Freenome's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Freenome in Biotechnology and South San Francisco
Companies Similar to Freenome
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Freenome Funding FAQs
What does Freenome do?
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention. Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.
How much funding has Freenome raised?
Freenome has raised $985M across 5 rounds on record. The most recent is an undisclosed round of $75.0M announced in Nov 2025.
When did Freenome last raise funding?
Freenome's most recent funding round on record is an undisclosed round of $75.0M, announced in Nov 2025.
Who founded Freenome?
FundedIQ lists Charles Roberts (Founder), Riley Ennis (Founder) at Freenome.
Who is the CEO of Freenome?
Gabriel Otte is listed as CEO at Freenome.
Where is Freenome headquartered?
Freenome is based in South San Francisco, California, United States.
How many employees does Freenome have?
Freenome is in the 251-500 employee band.
How does Freenome's funding compare to other Biotechnology startups?
Freenome's latest round of $75.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Freenome Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Freenome is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.